Publications by authors named "William J Sandborn"

594Publications

Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study.

Authors:
Séverine Vermeire Michael Chiorean Julián Panés Laurent Peyrin-Biroulet Jinkun Zhang Bruce E Sands Krisztina Lazin Preston Klassen Snehal U Naik Christopher H Cabell William J Sandborn

J Crohns Colitis 2021 Jan 21. Epub 2021 Jan 21.

University of California San Diego, La Jolla, CA, USA.

View Article and Find Full Text PDF
January 2021

Long-Term Efficacy And Safety Of Ozanimod In Moderate-To-Severe Ulcerative Colitis: Results From The Open-Label Extension Of The Randomized, Phase 2 Touchstone Study.

Authors:
William J Sandborn Brian G Feagan Stephen Hanauer Severine Vermeire Subrata Ghosh Wenzhong J Liu AnnKatrin Petersen Lorna Charles Vivian Huang Keith Usiskin Douglas C Wolf Geert D'Haens

J Crohns Colitis 2021 Jan 13. Epub 2021 Jan 13.

Inflammatory Bowel Disease Center, Amsterdam University Medical Center, Amsterdam, the Netherlands.

View Article and Find Full Text PDF
January 2021

An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials.

Authors:
Ahmed Almradi Christopher Ma Geert R D'Haens William J Sandborn Claire E Parker Leonardo Guizzetti Paula Borralho Nunes Gert De Hertogh Roger M Feakins Reena Khanna Gregory Y Lauwers Aart Mookhoek Reetesh K Pai Laurent Peyrin-Biroulet Robert Riddell Christophe Rosty David F Schaeffer Mark A Valasek Siddharth Singh Eileen Crowley Brian G Feagan Vipul Jairath Rish K Pai

Aliment Pharmacol Ther 2021 Jan 7. Epub 2021 Jan 7.

London, ON, Canada.

View Article and Find Full Text PDF
January 2021

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.

Authors:
Dan Turner Amanda Ricciuto Ayanna Lewis Ferdinando D'Amico Jasbir Dhaliwal Anne M Griffiths Dominik Bettenworth William J Sandborn Bruce E Sands Walter Reinisch Jürgen Schölmerich Willem Bemelman Silvio Danese Jean Yves Mary David Rubin Jean-Frederic Colombel Laurent Peyrin-Biroulet Iris Dotan Maria T Abreu Axel Dignass

Gastroenterology 2020 Dec 21. Epub 2020 Dec 21.

Department of Medicine I, Agaplesion Markus Hospital, Goethe University, Frankfurt/Main, Germany. Electronic address:

View Article and Find Full Text PDF
December 2020

Routine incorporation of the local read in Crohn's disease clinical trials? Not so fast.

Authors:
Vipul Jairath Guangyong Y Zou Christopher Ma Brian G Feagan William J Sandborn

Gastrointest Endosc 2021 Jan;93(1):183-186

Alimentiv Inc., London, Ontario, Canada; Division of Gastroenterology, University of California San Diego, La Jolla, California, USA.

View Article and Find Full Text PDF
January 2021

Early Combined Immunosuppression Reduces Complications in Long-standing Crohn's Disease: A Post Hoc Analysis of REACT.

Authors:
Jurij Hanzel Christopher Ma Guangyong Zou Siddharth Singh Parambir S Dulai Brian G Feagan Geert R D'Haens William J Sandborn Vipul Jairath

Clin Gastroenterol Hepatol 2020 Dec 18. Epub 2020 Dec 18.

Alimentiv Inc, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada; Division of Gastroenterology, Western University, London, Ontario, Canada. Electronic address:

View Article and Find Full Text PDF
December 2020

Frailty and Risk of Serious Infections in Biologic-treated Patients With Inflammatory Bowel Diseases.

Authors:
Siddharth Singh Herbert C Heien Lindsey Sangaralingham Nilay D Shah Jennifer C Lai William J Sandborn Alison A Moore

Inflamm Bowel Dis 2020 Dec 16. Epub 2020 Dec 16.

Division of Geriatrics and Gerontology, Department of Medicine, University of California San Diego, La Jolla, California, USA.

View Article and Find Full Text PDF
December 2020

Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases.

Authors:
Joseph Meserve Antonio Facciorusso Ariela K Holmer Vito Annese William J Sandborn Siddharth Singh

Aliment Pharmacol Ther 2021 Feb 12;53(3):374-382. Epub 2020 Dec 12.

Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.

View Article and Find Full Text PDF
February 2021

Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomized RIVETING Trial.

Authors:
Séverine Vermeire Chinyu Su Nervin Lawendy Taku Kobayashi William J Sandborn David T Rubin Irene Modesto Sean Gardiner Nicole Kulisek Haiying Zhang Wenjin Wang Julian Panés

J Crohns Colitis 2020 Dec 8. Epub 2020 Dec 8.

Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.

View Article and Find Full Text PDF
December 2020

Modeling Endoscopic Improvement after Induction Treatment with Mesalamine in Patients with Mild-to-Moderate Ulcerative Colitis.

Authors:
Christopher Ma Jenny Jeyarajah Leonardo Guizzetti Claire E Parker Siddharth Singh Parambir S Dulai Geert R D'Haens William J Sandborn Brian G Feagan Vipul Jairath

Clin Gastroenterol Hepatol 2020 Dec 3. Epub 2020 Dec 3.

Alimentiv (formerly Robarts Clinical Trials, Inc), London, Ontario, Canada; Division of Gastroenterology, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada. Electronic address:

View Article and Find Full Text PDF
December 2020

Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset Disease.

Authors:
Jacob J Rozich Jiyu Luo Parambir S Dulai Angelina E Collins Lysianne Pham Brigid S Boland William J Sandborn Siddharth Singh

Inflamm Bowel Dis 2020 Nov 30. Epub 2020 Nov 30.

Division of Gastroenterology, University of California San Diego, La Jolla, California, USA.

View Article and Find Full Text PDF
November 2020

Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease.

Authors:
Ariela K Holmer Robert Battat Parambir S Dulai Niels Vande Casteele Nghia Nguyen Anjali Jain Ara Miralles Jennifer Neill Helen Le Siddharth Singh Jesus Rivera-Nieves William J Sandborn Brigid S Boland

Therap Adv Gastroenterol 2020 12;13:1756284820971214. Epub 2020 Nov 12.

Inflammatory Bowel Disease Center, Division of Gastroenterology, Department of Medicine, University of California, San Diego, 9500 Gilman Drive, #0956, La Jolla, CA 92093-0956, USA.

View Article and Find Full Text PDF
November 2020

Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission.

Authors:
Hyuk Yoon Sushrut Jangi Parambir S Dulai Brigid S Boland Vipul Jairath Brian G Feagan William J Sandborn Siddharth Singh

Inflamm Bowel Dis 2020 Nov 25. Epub 2020 Nov 25.

Division of Gastroenterology, University of California San Diego, La Jolla, California, USA.

View Article and Find Full Text PDF
November 2020

Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease.

Authors:
Uma Mahadevan Millie D Long Sunanda V Kane Abhik Roy Marla C Dubinsky Bruce E Sands Russell D Cohen Christina D Chambers William J Sandborn

Gastroenterology 2020 Nov 20. Epub 2020 Nov 20.

Division of Gastroenterology and Hepatology, University of California San Diego, La Jolla, CA.

View Article and Find Full Text PDF
November 2020

Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis.

Authors:
William J Sandborn Laurent Peyrin-Biroulet Daniel Quirk Wenjin Wang Chudy I Nduaka Arnab Mukherjee Chinyu Su Bruce E Sands

Clin Gastroenterol Hepatol 2020 Oct 27. Epub 2020 Oct 27.

Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address:

View Article and Find Full Text PDF
October 2020

Contemporary Risk of Surgery in Patients with Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-based Cohorts.

Authors:
Lester Tsai Christopher Ma Parambir S Dulai Larry J Prokop Samuel Eisenstein Sonia L Ramamoorthy Brian G Feagan Vipul Jairath William J Sandborn Siddharth Singh

Clin Gastroenterol Hepatol 2020 Oct 27. Epub 2020 Oct 27.

Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California; Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California. Electronic address:

View Article and Find Full Text PDF
October 2020

Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing.

Authors:
Sushrut Jangi Hyuk Yoon Parambir S Dulai Mark Valasek Brigid S Boland Vipul Jairath Brian G Feagan William J Sandborn Siddharth Singh

Aliment Pharmacol Ther 2020 09 9;52(6):1008-1016. Epub 2020 Aug 9.

Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.

View Article and Find Full Text PDF
September 2020

Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.

Authors:
Remo Panaccione Silvio Danese William J Sandborn Christopher D O'Brien Yiying Zhou Hongyan Zhang Omoniyi J Adedokun Ilia Tikhonov Stephan Targan Maria T Abreu Tadakazu Hisamatsu Ellen J Scherl Rupert W Leong David S Rowbotham Ramesh P Arasaradnam Bruce E Sands Colleen Marano

Aliment Pharmacol Ther 2020 12 21;52(11-12):1658-1675. Epub 2020 Oct 21.

Spring House, PA, USA.

View Article and Find Full Text PDF
December 2020

National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United States.

Authors:
Nghia H Nguyen Rohan Khera Parambir S Dulai Brigid S Boland Lucila Ohno-Machado William J Sandborn Siddharth Singh

Inflamm Bowel Dis 2020 Oct 14. Epub 2020 Oct 14.

Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, CA, USA.

View Article and Find Full Text PDF
October 2020

Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice.

Authors:
Niels Vande Casteele Brian G Feagan Douglas C Wolf Anca Pop Mohamed Yassine Sara N Horst Timothy E Ritter William J Sandborn

Inflamm Bowel Dis 2020 Oct 14. Epub 2020 Oct 14.

Division of Gastroenterology, University of California San Diego, La Jolla, California, USA.

View Article and Find Full Text PDF
October 2020